New Methodological Approaches in The Development of Russian Live Attenuated Vaccine for Pandemic Influenza
Translational Biomedicine · 2015
DOI: 10.21767/2172-0479.100013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Biomedicine, 2015. Verfasst von Irina Kiseleva und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Avian influenza viruses remain a major pandemic threat. In response to this threat, a number of pandemic vaccines have been developed. The objective of this paper is to review and summarize data from preclinical and clinical evaluation of Russian live attenuated influenza vaccines (LAIVs) against pandemic influenza based on cold-adapted A/Leningrad/134/17/57 (H2N2) master donor virus (MDV). The described LAIVs consist of reassortant viruses of 6:2 and 7:1 genomic composition (6 MDV genes: 2 WT genes and 7 MDV genes: 1 WT gene, respectively). Despite the differences in their genomic composition (6:2 or 7:1), LAIV candidates of H5, H7 and H2 subtypes acquired temperature sensitivity, cold-adaptation, and attenuation for different animal models. In addition, they were safe and immunogenic for healthy adult volunteers. The collected data indicate that 7:1 reassortants carrying HA genes of potentially pandemic viruses and the remaining genes from the MDV might be preferable pandemic LAIV candidates.
Zitieren
APA
Kiseleva, I., & Larionova, N. (2015). New Methodological Approaches in The Development of Russian Live Attenuated Vaccine for Pandemic Influenza. Translational Biomedicine. https://doi.org/10.21767/2172-0479.100013
Vancouver
Kiseleva I, Larionova N. New Methodological Approaches in The Development of Russian Live Attenuated Vaccine for Pandemic Influenza. Translational Biomedicine. 2015. doi:10.21767/2172-0479.100013
BibTeX
@article{Kiseleva2015,
author = {Kiseleva, Irina and Larionova, Natalie},
title = {New Methodological Approaches in The Development of Russian Live Attenuated Vaccine for Pandemic Influenza},
journal = {Translational Biomedicine},
year = {2015},
doi = {10.21767/2172-0479.100013}
}
EUVIMED